Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Reversal of Anticoagulant Effect of Dabigatran® by Prothrombin Complex Concentrate (Beriplex®), Assessed With a Novel Method of Blood Loss Measurement

NCT02463591 is registered in ClinicalTrials.gov with University Medical Center Groningen as lead sponsor.

NCT NCT02463591
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02463591 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Reversal of Anticoagulant Effect of Dabigatran® by Prothrombin Complex Concentrate (Beriplex®), Assessed With a Novel Method of Blood Loss Measurement
Lead sponsor
University Medical Center Groningen
Phase
Phase 2
Overall status
Unknown status
Start date
January 31, 2015
Completion date
December 31, 2016
Enrollment
12 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

drug action reversal